We continue to take a deep dive into the “Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment” first-ever international conference on long COVID. Long-COVID research was always going to be a bit messy. Take a look at the...
A distinguished researcher proposes that plasmalogen deficiency plays a key role in ME/CFS and long COVID. While plasmalogen drugs are not available, plasmalogen supplements are. They do tend to be quite expensive, however.
Anticoagulant and anti-platelet therapy reduces symptoms significantly in long COVID. The implications for chronic fatigue syndrome (ME/CFS), fibromyalgia and POTS are discussed.
An innovative gene expression study suggests that an immune cell that's hardly been studied in chronic fatigue syndrome - monocytes - could be the prime driver of the immune problems in the disease.
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.